Print Email this page In the News

MDRNA, Inc., represented by Pryor Cashman, closed a registered direct offering raising gross proceeds of $10.5 million on June 12, 2009

MDRNA is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference.

The Pryor Cashman team was led by Partners Larry Remmel, Rich Frazer and Stephen Goodman, along with associates Danielle Schechner, Michael Campoli, Melissa Fleming and Sarah Selby.